(HealthDay)—"Financial toxicity" caused by high cancer drug prices is harming people's ability to fight the dreaded disease, a new report from the President's Cancer Panel warns.
Mar 13, 2018
0
5
Professor Chris Butler of the University of Oxford's Nuffield Department of Primary Care Health Sciences, and GP in the Cwm Taf University Health Board in Wales, is the lead investigator in the world's largest clinical trial ...
Jan 26, 2018
0
1
Despite federal programs to improve the availability of medical insurance, drug costs still keep more than one in ten stroke survivors from obtaining their recommended medications, putting them at risk of another stroke, ...
Jan 25, 2018
0
2
The high cost of prescription drugs in the United States came under scrutiny in a new report from the National Academies of Sciences, Engineering, and Medicines, "Making Medicines Affordable: A National Imperative," co-authored ...
Dec 4, 2017
0
0
Less than one-third of patients with glaucoma talk to their doctor about the costs of medications needed to control their disease, reports a study in the December issue of Optometry and Vision Science, the official journal ...
Dec 2, 2017
0
2
Physician and healthcare professional advocates from the American College of Rheumatology (ACR) are joined by rheumatology patients on Capitol Hill this week to urge lawmakers to address the significant drug cost and access ...
Sep 26, 2017
0
1
(HealthDay)—The first biosimilar drug to treat cancer has been approved by the U.S. Food and Drug Administration.
Sep 15, 2017
0
2
"It was the best of times, it was the worst of times" is a familiar quote from the opening of Charles Dickens' "A Tale of Two Cities," but the phrase is also applicable to the specialty drug market in the United States today.
Jul 6, 2017
0
0
About half of patients diagnosed with high blood pressure will need their medication adjusted within the first year to address side effects or failure to control blood pressure properly. Among the modification options available, ...
May 30, 2017
0
2
Use of the generic versions of directly-acting antiviral (DAA) drugs that are available in India to treat hepatitis C virus (HCV) infection is not only cost effective but actually saves lifetime costs for treating infected ...
May 17, 2017
0
0
